We invite you to join our Industrial Bioprocessing Course. We are planning a 5-day professional short course delivered virtually over 5 weeks from February 1 - March 5. There will be live questions and answers and Networking sessions after each module. The course will be taught by industry professionals from BMS, Pfizer, MilliporeSigma, and UMass experts.
The trainees will learn key principles and concepts of industrial bioprocessing of protein, cell and gene therapies. The course covers recent technologies and practices of upstream, downstream and analytical bioprocessing technologies. In addition, FDA initiatives of PAT (Process Analytical Technology), Quality by Design, and Emerging Technology will be covered. The course consists of 7 modules.
Who Can Benefit from this Professional Course?